HER2 and ABCC1 are identified as significant transcriptomic predictors of overall survival in patients treated with T-DXd. A large-scale analysis reveals novel predictors of survival and resistance ...
Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...
Researchers have revealed how patients with metastatic breast cancer develop resistance to Enhertu treatment.
AZoLifeSciences on MSN
Novel epigenetic regulator enhances downy mildew resistance in Brassica rapa
Downy mildew is a major constraint on Brassica crop production worldwide, especially during early developmental stages when ...
The market for microbiome sample preparation technology presents opportunities driven by demand for personalized medicine, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results